FILTER

FILTERED INTERVIEW RESULTS

Roel Schaapveld

CEO, INTERNA TECHNOLOGIES
InteRNA Technologies explains the promise of microRNA therapeutics.

Federico Chinni

MANAGING DIRECTOR, UCB ITALY
UCB Italy explains the specifications of the Italian health and pharma sector.

Paula Brown Stafford

PRESIDENT & CEO, NOVAN
Novan explains its vision to be the world’s leading nitric oxide-based science, technology and clinical translation company.

Dr. Donald Gerson

COO & CO-FOUNDER, SAUDIVAX
SaudiVax provides an insight into the nascent biotech industry in Saudi Arabia.

Swapnil Shah

MANAGING DIRECTOR, ESPEE GROUP
Espee Group speaks about how the demand for drugs is changing.

Fabrizio Chines

CHAIRMAN & CEO, SIFI GROUP
SIFI Group explains its pipeline and its plans for expansion in the ophthalmology space.

Maurizio Sartorato

CEO BIDACHEM SPA
Bidechem SPA explains its strategy for sustainable business growth.

Massimo Scaccabarozzi

PRESIDENT, FARMINDUSTRIA
Farmindustria speaks to GBR about the importance of pharmaceuticals to the Italian economy and society.

Shankar Musunuri

CHAIRMAN, CEO & CO-FOUNDER, OCUGEN
Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.

Massimiliano Rocchi

SENIOR DIRECTOR ITALY AND GREECE, ACCORD HEALTHCARE ITALIA
Accord Healthcare Italia explains the challenges and opportunities for generics producers in Italy.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Québec and Atlantic Canada Mining 2025

Québec and Atlantic Canada have traversed 2025 in an enviable position. Strong gold prices have buoyed balance sheets and investor sentiment, while global demand for critical minerals keeps the region firmly on the radar of international markets. At the same time, the provinces’ depth of mining expertise – from AI-driven exploration to advanced drilling, blasting, and geophysics – ensures that technological advantage is firmly on their side.

PARTNER EVENTS